Source: ACI Clinical Blog

ACI Clinical Blog Overcoming CDISC Data Conversion Challenges for FDA Submissions

In order to help standardize clinical research data across the industry and expedite the drug approval process, the FDA mandated in 2016 that all clinical trial data for a drug program must be submitted to the FDA in CDISC data standard format. Therefore, it is highly important that sponsors [...]The post Overcoming CDISC Data Conversion Challenges for FDA Submissions appeared first on ACI Clinical.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jonathan Seltzer's photo - President & CEO of ACI Clinical

President & CEO

Jonathan Seltzer

CEO Approval Rating

69/100

Read more